To expand the validation of the observed USP1-PARP1 interaction, we performed confirmatory CO-IP assays in the CCA cell lines HuCC-T1, HCCC-9810, RBE, and HEK-293T (Fig. 1D–H). The gene discussed is PARP1; the disease is cholangiocarcinoma.